This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1990 Nov 3;336(8723):1130.

doi: 10.1016/0140-6736(90)92606-i.

Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis

F Cervantes, C Salgado, E Montserrat, C Rozman

PMID: 1700245
DOI: 10.1016/0140-6736(90)92606-i

Case Reports

Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis

F Cervantes et al. Lancet. 1990.

. 1990 Nov 3;336(8723):1130.

doi: 10.1016/0140-6736(90)92606-i.

Authors

F Cervantes, C Salgado, E Montserrat, C Rozman

PMID: 1700245
DOI: 10.1016/0140-6736(90)92606-i

No abstract available

PubMed Disclaimer

Similar articles

Pulmonary toxicity associated with fludarabine monophosphate.
Hurst PG, Habib MP, Garewal H, Bluestein M, Paquin M, Greenberg BR. Hurst PG, et al. Invest New Drugs. 1987;5(2):207-10. doi: 10.1007/BF00203548. Invest New Drugs. 1987. PMID: 2443463
Fludarabine monophosphate for prolymphocytic leukaemia.
Smith OP, Mehta AB. Smith OP, et al. Lancet. 1990 Sep 29;336(8718):820. doi: 10.1016/0140-6736(90)93293-x. Lancet. 1990. PMID: 1698237 No abstract available.
Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.
List AF, Kummet TD, Adams JD, Chun HG. List AF, et al. Am J Med. 1990 Sep;89(3):388-90. doi: 10.1016/0002-9343(90)90358-k. Am J Med. 1990. PMID: 1697447 No abstract available.
Tumor lysis syndrome induced by fludarabine monophosphate: a case report.
Nakhoul F, Green J, Abassi ZA, Carter A. Nakhoul F, et al. Eur J Haematol. 1996 Apr;56(4):254-5. doi: 10.1111/j.1600-0609.1996.tb01939.x. Eur J Haematol. 1996. PMID: 8641396 Review. No abstract available.
Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.
Robertson LE, Keating MJ. Robertson LE, et al. Cancer Treat Res. 1993;64:105-19. doi: 10.1007/978-1-4615-3086-2_6. Cancer Treat Res. 1993. PMID: 7680874 Review. No abstract available.

See all similar articles

Cited by

Management of chronic lymphocytic leukaemia.
Kalil N, Cheson BD. Kalil N, et al. Drugs Aging. 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. Drugs Aging. 2000. PMID: 10733261 Review.
Corticosteroid-responsive pulmonary toxicity associated with fludarabine monophosphate: a case report.
Rudzianskiene M, Griniute R, Juozaityte E, Inciura A, Rudzianskas V, Emilia Kiavialaitis G. Rudzianskiene M, et al. Turk J Haematol. 2012 Dec;29(4):392-6. doi: 10.5505/tjh.2012.50490. Epub 2012 Dec 5. Turk J Haematol. 2012. PMID: 24385727 Free PMC article.
Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.
Adkins JC, Peters DH, Markham A. Adkins JC, et al. Drugs. 1997 Jun;53(6):1005-37. doi: 10.2165/00003495-199753060-00007. Drugs. 1997. PMID: 9179529 Review.
Lysis pneumonopathy associated with the use of fludarabine phosphate.
Crowley JJ, Knight L, Charan N. Crowley JJ, et al. West J Med. 1994 Dec;161(6):597-9. West J Med. 1994. PMID: 7531920 Free PMC article. No abstract available.
Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.
Ross SR, McTavish D, Faulds D. Ross SR, et al. Drugs. 1993 May;45(5):737-59. doi: 10.2165/00003495-199345050-00009. Drugs. 1993. PMID: 7686467 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information